over its plans to make a generic version of Cephalon Inc.

muscle relaxant Amrix can go forward, largely denying an Anchen dismissal motion in the case, which...

(KG), Pain Therapeutics, Inc.

(PTIE) King Pharmaceuticals, Inc.

(KG) reported fourth-quarter earnings of 23 cents per share, a penny below the Zacks Consensus Estimate.

Despite fourth quarter...

(AP) ' Biotechnology company Cephalon Inc.

said Thursday its fourth-quarter profit surged on a boost in sales and lower charges.

Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago,...

said yesterday that its fourth-quarter profit surged on a boost in sales and lower charges.

Frazer-based Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when...

said yesterday that its fourth-quarter profit surged on a boost in sales and lower charges.

Frazer-based Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when...

said Thursday its fourth-quarter profit surged on a boost in sales and lower charges.

Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when the company...

Biotechnology company Cephalon Inc.

said Thursday its fourth-quarter profit surged on a boost in sales and lower charges.

Cephalon earned $96.6 million, or $1.23 per share, compared with $5 million, or 6 cents per share, a year ago, when the...

-- Biotechnology company Cephalon Inc.

said Thursday its fourth-quarter profit surged on a boost in sales and lower charges.

Cephalon Excluding the charges, the company said it earned $1.66 per share during the most recent quarter, compared...